ZVSA Annual Cash & Cash Equivalents
$3.14 M
-$2.76 M-46.84%
01 December 2023
Summary:
As of January 23, 2025, ZVSA annual cash & cash equivalents is $3.14 million, with the most recent change of -$2.76 million (-46.84%) on December 1, 2023. During the last 3 years, it has risen by +$2.96 million (+1696.05%). ZVSA annual cash & cash equivalents is now -46.84% below its all-time high of $5.90 million, reached on December 31, 2022.ZVSA Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ZVSA Quarterly Cash And Cash Equivalents
$122.90 K
+$3400.00+2.85%
01 September 2024
Summary:
As of January 23, 2025, ZVSA quarterly cash and cash equivalents is $122.90 thousand, with the most recent change of +$3400.00 (+2.85%) on September 1, 2024. Over the past year, it has dropped by -$1.91 million (-93.96%). ZVSA quarterly cash and cash equivalents is now -97.92% below its all-time high of $5.90 million, reached on December 31, 2022.ZVSA Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ZVSA Cash And Cash Equivalents Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -46.8% | -94.0% |
| 3 y3 years | +1696.0% | +290.2% |
| 5 y5 years | +1696.0% | +290.2% |
ZVSA Cash And Cash Equivalents High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -46.8% | +854.9% | -97.9% | +290.2% |
| 5 y | 5-year | -46.8% | +1696.0% | -97.9% | +290.2% |
| alltime | all time | -46.8% | +1696.0% | -97.9% | +290.2% |
ZyVersa Therapeutics Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $122.90 K(+2.8%) |
| June 2024 | - | $119.50 K(-94.1%) |
| Mar 2024 | - | $2.03 M(-35.2%) |
| Dec 2023 | $3.14 M | $3.14 M(+98.8%) |
| Sept 2023 | - | $1.58 M(+590.3%) |
| June 2023 | - | $228.70 K(-82.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2023 | - | $1.28 M(-78.3%) |
| Dec 2022 | $5.90 M(+1696.2%) | $5.90 M(+879.1%) |
| Sept 2022 | - | $602.80 K(+1813.7%) |
| June 2022 | - | $31.50 K(-90.4%) |
| Dec 2021 | $328.60 K(+88.1%) | - |
| Dec 2021 | - | $328.60 K |
| Dec 2020 | $174.70 K | - |
FAQ
- What is ZyVersa Therapeutics annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for ZyVersa Therapeutics?
- What is ZyVersa Therapeutics annual cash & cash equivalents year-on-year change?
- What is ZyVersa Therapeutics quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for ZyVersa Therapeutics?
- What is ZyVersa Therapeutics quarterly cash and cash equivalents year-on-year change?
What is ZyVersa Therapeutics annual cash & cash equivalents?
The current annual cash & cash equivalents of ZVSA is $3.14 M
What is the all time high annual cash & cash equivalents for ZyVersa Therapeutics?
ZyVersa Therapeutics all-time high annual cash & cash equivalents is $5.90 M
What is ZyVersa Therapeutics annual cash & cash equivalents year-on-year change?
Over the past year, ZVSA annual cash & cash equivalents has changed by -$2.76 M (-46.84%)
What is ZyVersa Therapeutics quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of ZVSA is $122.90 K
What is the all time high quarterly cash and cash equivalents for ZyVersa Therapeutics?
ZyVersa Therapeutics all-time high quarterly cash and cash equivalents is $5.90 M
What is ZyVersa Therapeutics quarterly cash and cash equivalents year-on-year change?
Over the past year, ZVSA quarterly cash and cash equivalents has changed by -$1.91 M (-93.96%)